FMS News and Press, Fresenius Medical Care AG From 10/10/22

Jefferies downgraded the Fresenius Medical Care ( NYSE: FMS ) ( OTCPK:FSNUF ) ( OTCPK:FSNUY ) to Hold from Buy on Monday as the analysts pointed out that the staffing shortages and inflation could hurt the dialysis provider even after the company reported an improvemen...

Fresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE Award PR Newswire The CARE Award Honors Frontline Nephrology Care Team Members for Embodying the Company's Core Values WALTHAM, Mass. , Sept. 12, 2022 /PRNewswire/ -- Fresenius ...

Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. US inflation is softening in July but continues to...

The Kidney Kid Corporate Responsibility Program to reach more children and their families to promote kidney health in Malaysia Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today signed a memoran...

Fresenius ( NYSE: FMS ) on Tuesday said it had been awarded a contract from the U.S. Department of Veterans Affairs (VA) to provide dialysis services to military veterans. The VA awarded a five-year contract to Fresenius Medical North America's (FMCNA) Renal Ther...

Fresenius Medical Care Wins Major Award to Support U.S. Veterans with Industry-Leading Dialysis Care PR Newswire The Department of Veterans Affairs Approves Purchase of FMCNA Products in Five Categories WALTHAM, Mass. , Aug. 30, 2022 /PRNewswire/ ...

Summary Tweedy, Browne’s 13F portfolio value decreased from $3.10B to $2.45B this quarter. They added FedEx Corp., American Express, and Paramount Global while decreasing AutoZone and dropping 3M. Alphabet at ~18% of the portfolio is the largest position. This...

German health services company Fresenius Medical Care AG & Co. ( NYSE: FMS ) ( OTCPK:FMCQF ) announced Friday that the head of its pharmaceutical division Michael Sen would become the company’s new Chief Executive effective Oct. 01. Sen will replace Freseniu...

The Swiss Agency for Therapeutic Products (Swissmedic) approved Cara Therapeutics ( NASDAQ: CARA ) and Vifor Fresenius Medical Care Renal Pharma's Kapruvia (difelikefalin) to treat moderate-to-severe pruritus (itching) associated with chronic kidney disease ...

The shares of Fresenius, one of the world's largest healthcare groups, have been in a downward and then a sideways trend since 2017. Corona pandemic has been a major challenge, especially for its subsidiary Fresenius Medical Care. Despite further waves of infection, the worst of the c...